PRLD

NASDAQ · Biotechnology

Prelude Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.07

+0.24 (+4.97%)

As of Aug 15, 2:15 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +85.8% upside

Low Target $6.99

Average Target $9.42

High Target $10.52

Current Price $5.07

Current
$5.07

Target
$9.42

$6.99 $9.42 avg $10.52

Scenario Analysis

Bear Case

$6.99

37.9%

Low target

Base Case

$9.42

+85.8%

Avg target

Bull Case

$10.52

+107.5%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$5.91

-14.2% from high

52-Week Low

$0.81

+523.7% from low

Target vs 52W High

$9.42

+59.4% vs high

Next Earnings Report

Aug 19, 2026

until earnings

EPS Est: $-0.20

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%